Evozyne Revenue and Competitors

Chicago, IL USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Evozyne's estimated annual revenue is currently $10.4M per year.(i)
  • Evozyne's estimated revenue per employee is $185,446

Employee Data

  • Evozyne has 56 Employees.(i)
  • Evozyne grew their employee count by 4% last year.

Evozyne's People

NameTitleEmail/Phone
1
Executive Assistant to the CEOReveal Email/Phone
2
Chief Scientific OfficerReveal Email/Phone
3
CEOReveal Email/Phone
4
ControllerReveal Email/Phone
5
VP, Protein EngineeringReveal Email/Phone
6
Head Mammalian Cell Culture R&DReveal Email/Phone
7
General CounselReveal Email/Phone
8
Senior Director, Talent + HRReveal Email/Phone
9
Chief Drug Discovery OfficerReveal Email/Phone
10
Director Information TechnologyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.8M18-14%N/AN/A
#2
$0.8M50%N/AN/A
#3
$2M130%N/AN/A
#4
$707.3M26559%$1.1BN/A
#5
$1.7M110%N/AN/A
#6
$32.6M2106%N/AN/A
#7
$2.6M176%N/AN/A
#8
$1.1M7-30%N/AN/A
#9
$1.4M9-10%N/AN/A
#10
$2M138%N/AN/A
Add Company

What Is Evozyne?

Evozyne is a data-driven evolution-based molecular engineering platform for building novel, application-specific proteins with advanced functionality.

keywords:N/A

N/A

Total Funding

56

Number of Employees

$10.4M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Evozyne News

2022-04-06 - Takeda/Evozyne Partnership Headlines Hot Week for Gene ...

Evozyne delivered its first protein to Takeda within six months and then went on to design a library of novel proteins with better functionality...

2022-04-06 - Evozyne Announces Multi-Target Research Collaboration and ...

Evozyne combines evolution and deep learning technology to create highly functional novel proteins — Natural Machines™ — to solve longstanding...

2022-04-06 - Takeda returns to Evozyne's AI tech, seeking novel proteins ...

Evozyne uses artificial intelligence and machine learning to design novel proteins that can be used in gene therapies. The new agreement with...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$13.6M56-7%N/A
#2
$7.3M564%N/A
#3
$6M56-14%N/A
#4
$13.2M56-30%$10.5M
#5
$35M564%N/A